Sort   by:  
 Page size 
UnknownPD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma.
Not available
S-EPMC4927341 | biostudies-literature
UnknownLong-term outcomes to neoadjuvant pembrolizumab based on pathological response for patients with resectable stage III/IV cutaneous melanoma.
Not available
S-EPMC11232562 | biostudies-literature
UnknownCeragenins and Antimicrobial Peptides Kill Bacteria through Distinct Mechanisms.
Not available
S-EPMC8787472 | biostudies-literature
UnknownAdo-trastuzumab emtansine (T-DM1) in patients with HER2-amplified tumors excluding breast and gastric/gastroesophageal junction (GEJ) adenocarcinomas: results from the NCI-MATCH trial (EAY131) subprotocol Q.
Not available
S-EPMC6927318 | biostudies-literature
UnknownNivolumab Is Effective in Mismatch Repair-Deficient Noncolorectal Cancers: Results From Arm Z1D-A Subprotocol of the NCI-MATCH (EAY131) Study.
Not available
S-EPMC6968795 | biostudies-literature
UnknownCrizotinib in patients with tumors harboring ALK or ROS1 rearrangements in the NCI-MATCH trial.
Not available
S-EPMC8888601 | biostudies-literature
ProteomicsBlood-based Diagnostics of Pediatric Tuberculosis: A Prospective Case-controlled Study
Background Pediatric tuberculosis (TB) diagnosis is often challenging due to difficultly obtaining diagnostic respiratory specimens, which may contain low concentrations of Mycobacterium tuberculosis (Mtb) bacilli. However, we have reported that an immuno-affinity liquid chromatography-tandem mass s...
ORGANISM(S): Homo Sapiens 
PXD053274 | panorama
GenomicsRNA-RNA interactions enable specific targeting of noncoding RNAs to nascent pre-mRNAs and chromatin sites
We developed a general method based on RNA Antisense Purification (RAP) to identify the intermolecular RNA-RNA interactions of a target RNA (RAP-RNA). RAP-RNA identifies endogenous RNA-RNA complexes through in vivo crosslinking, RNA capture with antisense oligonucleotides, and high-throughput RNA se...
ORGANISM(S): Mus musculus 
2014-09-01 | E-GEOD-55914 | biostudies-arrayexpress
UnknownDART/SWOG/NCI phase II anti-CTLA-4/PD-1 trial: clear cell carcinomas of ovary, endometrium, cervix.
Not available
S-EPMC12911695 | biostudies-literature
TranscriptomicsComparative genomic hybridization of Clostridium sporogenes and Clostridium botulinum strains
Clostridium botulinum is a heterogeneous Gram-positive species that comprises four genetically and physiologically distinct groups of bacteria that share the ability to produce botulinum neurotoxin, the most poisonous toxin known to man, and the causative agent of botulism, a severe disease of human...
ORGANISM(S): Clostridium botulinum 
2007-05-23 | E-TABM-264 | biostudies-arrayexpress
Sort   by:  
 Page size